NEW YORK (GenomeWeb News) – UCB Canada said today it will support a multi-partner research project funded by Genome Canada and Genome Quebec by helping to study the genomes of epilepsy patients and analyzing genes involved in their responses to medications.

Montreal-based UCB said it will use a C$200,000 (US$188,000) grant to fund its contribution to the C$10.8 million project, which launched earlier this year and created the Canadian Epilepsy Network (CENet).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.